Epsom Salts

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Epsom Salts
Generic name: MAGNESIUM SULFATE
Manufacturer: NEW PRIDE CORP
Product type: HUMAN OTC DRUG
SPL set ID: f6626023-4857-518b-e053-2a95a90a9821
SPL ID: 299acaea-3ece-c645-e063-6294a90a8401
Version: 3
Effective date: 2024-12-19
Source export date: 2026-10-27
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/2eee27992d1f29d82f827fd5be42f1314ed39ce4c497af5d81435ac6656a0957/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:22:31

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M007	openfda.application_number
brand name		Epsom Salts	openfda.brand_name
generic name		MAGNESIUM SULFATE	openfda.generic_name
manufacturer name		NEW PRIDE CORP	openfda.manufacturer_name
ndc	package	58037-008-01	openfda.package_ndc
ndc	product	58037-008	openfda.product_ndc
ndc11	package	58037000801	derived:openfda.package_ndc
rxcui		1053346	openfda.rxcui
spl id		299acaea-3ece-c645-e063-6294a90a8401	id
spl set id		f6626023-4857-518b-e053-2a95a90a9821	set_id
unii		SK47B8698T	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Ask a doctor before use if you have Kidney Disease A magnesium restricted diet Abdominal pain, nausea or vomiting Noticed a sudden change in bowel habits that persists over a period of 2 weeks Already used a laxative for a period of longer than 1 week If pregnant or breast-feeding ask a health profesional before use

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.